Are We at the End of the Pandemic?

For nearly a year, experts have noted that the COVID shots cannot establish herd immunity to end the pandemic, as the gene transfer injections do not prevent infection or transmission. It’s not rocket science, yet health officials and government leaders around the world have irrationally claimed otherwise, and censored any and all — regardless of… Read More »

22 Ways to Stop Vaccine Passports

Vaccine passports are poised to change the world as you know it, creating a digital trail of your every move. Right now, it’s injection status that’s being highlighted, but the end goal is to surveil and collect not only medical information but financial transactions, political affiliations, religious and philosophical beliefs and more. Some have speculated… Read More »

Health Risks of Physical Inactivity

This article was previously published May 15, 2020, and has been updated with new information. Decades of fitness research remind us that physical activity is one of the best preventive measures available. It’s one of the pillars of good health alongside nutrition, sleep and hydration. Evidence has demonstrated the effect that exercise has on sleep… Read More »

11:11 Systems Completes Acquisition of iland

Combined Offering to Unlock the Power of Connectivity, Cloud and Security Newly-formed 11:11 answers cloud market’s call for a single, trusted vendor to manage and monitor hybrid infrastructure iland and previous acquisition, Green Cloud Defense, to serve as core ingredient platforms in 11:11 market-leading offerings LONDON, UK – 20th January 2022 – 11:11 Systems (“11:11”),… Read More »

Record year 2021: Platform provider Visable reports 66 million euro turnover

Hamburg, 12 January 2022 – Visable, the provider of Europe’s leading B2B platforms EUROPAGES and wlw (formerly “Wer liefert was”), reports its most successful year yet: Overall, the company was able to achieve a profitable record turnover of 66 million euros. This constitutes a growth of 14 per cent compared to the previous year. “We… Read More »

Eye Drops to Replace Your Reading Glasses?

The U.S Food and Drug Administration approved prescription eye drops, called Vuity, to treat presbyopia, commonly known as age-related farsightedness. People with presbyopia have trouble focusing on objects close up, and it commonly affects people beginning in their early- to mid-40s, progressively worsening until about age 65.1 If you have presbyopia, you may find that… Read More »